The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
Abstract
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as Leigh syndrome. Both patients were homozygous for an Arg554Trp substitution in the Fp subunit. Their parents (first cousins) were heterozygous for the mutation that occurred in a conserved domain of the protein and was absent from 120 controls. The deleterious effect of the Arg to Trp substitution on the catalytic activity of SDH was observed in a SDH- yeast strain transformed with mutant Fp cDNA. The Fp subunit gene is duplicated in the human genome (3q29; 5p15), with only the gene on chromosome 5 expressed in human-hamster somatic cell hybrids. This is the first report of a nuclear gene mutation causing a mitochondrial respiratory chain deficiency in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“consistent with results of clinical studies linking SdhA mutations to a bioenergetic deficiency rather than a tumor phenotype (7).”
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Diseases of the mitochondrial DNA
Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243
Self-citationIn situ hybridization; a practical approach
(1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90093-t · Cited by 1,220
The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains
Walker, J. E. (1992) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350000425x · Cited by 781
One-step transformation of yeast in stationary phase
Chen, D.-C., Yang, B.-C., & Kuo, T.-T. (1992) · Current Genetics · doi:10.1007/bf00318659 · Cited by 697
In situ hybridization; a practical approach
(1993) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(93)90060-h · Cited by 648
Pearson's marrow–pancreas syndrome. A multisystem mitochondrial disorder in infancy
Rötig, A., Cormier, V, Blanche, S., Bonnefont, J. P., Ledeist, F., Romero, N., Schmitz, J., Rustin, P., Fischer, A., & Saudubray, J. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114881 · Cited by 461
Self-citationMandel, J. L., & Chambon, P. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.8.2081 · Cited by 348
Clinical aspects of mitochondrial disorders
Münnich, A., Rustin, P., Rötig, A., Chrétien, D., Bonnefont, J., Nuttin, C., Cormier‐Daire, V., Vassault, A. J., Parvy, P., Bardet, J., et al. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799603 · Cited by 153
Self-citation
Research works printed but not linked: 1
- Ackrell, B.A.C., Johnson, M.K., Gunsalus, R.P. & Cecchini, G. Structure and function of succinate dehydrogenase and fumarate reductase. In Chemistry and Biochemistry of Flavoproteins (ed. Muller, F.) 3, 229–297 (CRC Press, Inc., Boca Raton, FL, 1990).
Cited by
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
“On the other hand, mutations in the SDHA (FAD-containing subunit) cause the mitochondrial encephalomyopathy Leigh syndrome (19) but not paraganglioma.”
BackgroundMitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,661
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
“SDHA mutations are associated with juvenile encephalopathy (Bourgeron et al. 1995), and the phenotypic consequences of SDHB mutations have not been defined.”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927
Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II
Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., & Rao, Z. (2005) · Cell · doi:10.1016/j.cell.2005.05.025 · Cited by 881
“The conservation of the Qp binding pocket from E. coli to mammalian Q TSQR implies a similar mechanism of electron transfer from succinate to ubiquinone at the Qp site. c tNear the intermembrane side, with the aid of the bound TTFA2 inhibitor, we identified a second ubiqui- ( none binding pocket (Figure 4D) formed by…”
BackgroundInfluentialBrowne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
Mitochondrial mutations in cancer
Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 818
“However, mutations in SDH A cause the lethal pediatric neurodegenerative disease Leigh’s syndrome (Bourgeron et al., 1995), not paraganglioma.”
BackgroundMitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Mitochondrial disorders as windows into an ancient organelle
Vafai, S. B., & Mootha, V. K. (2012) · Nature · doi:10.1038/nature11707 · Cited by 737
The genetics and pathology of oxidative phosphorylation
Smeitink, J., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 724
“gif" NDATA ITEM> ]> Among the different groups of inborn errors of metabolism, mitochondrial disorders are the most frequent, with an estimated incidence of at least 1 in 10,000 live birth”
BackgroundA mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.
Ishii, N., Fujii, M., Hartman, P. S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Ayusawa, D., & Suzuki, K. (1998) · Nature · doi:10.1038/29331 · Cited by 687
“Compared with defects in the other four complexes, abnormalities in complex II are rare and clinical presentation varies among individual”
BackgroundSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
“Although ‘type I Fp’ SDHA was located on chromosome 5 (5p15) (6), the location of the putative ‘type II Fp’ intronless gene was never identified.”
BackgroundSelf-citationZhu, Z., Yao, J., Johns, T., Fu, K., Bie, I. D., Macmillan, C., Cuthbert, A. P., Newbold, R. F., Wang, J.-C., Chevrette, M., et al. (1998) · Nature Genetics · doi:10.1038/3804 · Cited by 623
“and a mutation in the F p subunit of succinate dehydrogenas”
BackgroundMitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Function and Structure of Complex II of the Respiratory Chain
Cecchini, G. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161700 · Cited by 556
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patocs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 539
Mutations of SURF-1 in Leigh Disease Associated with Cytochrome c Oxidase Deficiency
Tiranti, V., Hoertnagel, K., Carrozzo, R., Galimberti, C., Munaro, M., Granatiero, M., Zelante, L., Gasparini, P., Marzella, R., Rocchi, M., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302150 · Cited by 529
“…c oxidase [COX]) was found in the majority of our patients (Zeviani et al. 1996), although deficiencies of the pyruvate dehydrogenase complex, respiratory complexes I (Rahman et al. 1996) or II (Bourgeron et al. 1995), and mtDNA point mutations (Santorelli et al. 1993) have been reported by others.”
BackgroundLeigh syndrome: One disorder, more than 75 monogenic causes
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. (2016) · Annals of Neurology · doi:10.1002/ana.24551 · Cited by 497
“subunit SDHA were the first nuclear mutations identified to cause OXPHOS disease.(29) Some patients with SDHA”
BackgroundMinimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
“Respiratory chain disorders are claimed to occur with a frequency of 1/5000 to 1/10 000 births (Robinson, 1993; Bourgeron et al., 1995; Smeitink et al., 1998).”
BackgroundEnergetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
Succinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
“Bourgeron et al. reported an increased sensitivity of SDHA to the inhibitory effect of oxaloacetate (OAA), and speculated that the mutation could alter SDHA's conformation or redox state which might alter enzyme catalysis and response to OAA (Bourgeron et al., 1995 ).”
BackgroundThe genetics and pathology of mitochondrial disease
Alston, C. L., Rocha, M. C., Lax, N. Z., Turnbull, D. M., & Taylor, R. W. (2017) · The Journal of Pathology · doi:10.1002/path.4809 · Cited by 451
“The first nuclear mitochondrial gene mutation was identified in 1995 in SDHA, encoding a structural subunit of complex II [25], and there has been monumental progress in the discovery of mitochondrial disease candidate genes since then.”
BackgroundSuccinate: quinone oxidoreductases
Hägerhäll, C. (1997) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(97)00019-4 · Cited by 437
Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
“In contrast, cell proliferation and tumor growth rates in SdhA shRNA cells were inhibited, consistent with results of clinical studies linking SdhA mutations to a bioenergetic deficiency rather than a tumor phenotype (7).”
ResultStructure of the Escherichia coli Fumarate Reductase Respiratory Complex
Iverson, T. M., Luna-Chavez, C., Cecchini, G., & Rees, D. C. (1999) · Science · doi:10.1126/science.284.5422.1961 · Cited by 416
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
Biochemical Assays of Respiratory Chain Complex Activity
Kirby, D. M., Thorburn, D. R., Turnbull, D. M., & Taylor, R. W. (2007) · Methods in Cell Biology · doi:10.1016/s0091-679x(06)80004-x · Cited by 384
Leigh and Leigh-Like Syndrome in Children and Adults
Finsterer, J. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.07.013 · Cited by 378
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
“The causative mutation was identified in the SDHA gene encoding the flavoprotein of complex II, and the enzymatic defect was partial (Bourgeron et al. 1995).”
BackgroundSelf-citationBirch-Machin, M. A., & Turnbull, D. M. (2001) · Methods in Cell Biology · doi:10.1016/s0091-679x(01)65006-4 · Cited by 367
Self-citationSuccinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity
Finley, L. W. S., Haas, W., Desquiret-Dumas, V., Wallace, D. C., Procaccio, V., Gygi, S. P., & Haigis, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023295 · Cited by 362
“For example, the R554W mutation in humans reduces SDH activity and is associated with Leigh’s syndrome [27].”
BackgroundGenetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
“…years, homozygous and compound heterozygous mutations in the gene encoding the fourth subunit, SDHA, were associated with a rare early-onset R258 neurodegenerative disorder called Leigh syndrome (Bourgeron et al. 1995, Horvath et al. 2006), but neither with PCCs nor with PGLs (Bayley et al. 2005).”
BackgroundThe clinical maze of mitochondrial neurology
DiMauro, S., Schon, E. A., Carelli, V., & Hirano, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.126 · Cited by 353
Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases
Fiskum, G., Murphy, A. N., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00001 · Cited by 350
Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
“Interestingly, germline mutations in SDHA have not been associated with neoplasia but can cause an autosomal recessive juvenile encephalopathy [Bourgeron et al., 1995].”
BackgroundA neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 316
Mitochondrial disorders of the OXPHOS system
Fernandez‐Vizarra, E., & Zeviani, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.13995 · Cited by 305
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295
“Leigh syndrome arises from a broad spectrum of genetic defects, with mutations in mitochondrial and nuclear genes [29] including mutations in SDHA [30].”
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
Albers, D. S., & Flint Beal, M. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297
Mutations in the humanTWIST gene
Gripp, K. W., Zackai, E. H., & Stolle, C. A. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200002)15:2<173::aid-humu6>3.0.co;2-w · Cited by 114
Isolated complex I deficiency in children: Clinical, biochemical and genetic aspects
Loeffen, J. L. C. M., Smeitink, J. A. M., Trijbels, J. M. F., Janssen, A. J. M., Triepels, R. H., Sengers, R. C. A., & van den Heuvel, L. P. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200002)15:2<123::aid-humu1>3.0.co;2-p · Cited by 288
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Mitochondrial medicine in the omics era
Rahman, J., & Rahman, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30727-x · Cited by 283
“The search for nuclear gene mutations causing OXPHOS deficiency remained elusive until the identification of SDHA mutations in a patient with Leigh syndrome caused by deficiency of complex II, the only OXPHOS complex entirely encoded by nuclear genes.(41) Despite this breakthrough, for many years most cases of mitocho…”
Mitochondria in Huntington's disease
Damiano, M., Galvan, L., Déglon, N., & Brouillet, E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.012 · Cited by 284
“Loss of function in the gene coding one of the succinate dehydrogenase (SDHA) determines Leigh syndrome [57].”
BackgroundThe First Nuclear-Encoded Complex I Mutation in a Patient with Leigh Syndrome
Loeffen, J., Smeitink, J., Triepels, R., Smeets, R., Schuelke, M., Sengers, R., Trijbels, F., Hamel, B., Mullaart, R., & van den Heuvel, L. (1998) · The American Journal of Human Genetics · doi:10.1086/302154 · Cited by 285
“…autosomal recessive, with defects described in biotinidase (Baumgartner et al. 1989), pyruvate dehydrogenase complex (PDHc), OXPHOS complex II (Bourgeron et al. 1995), and complex IV (Willems et al. 1977); X-linked recessive, with defects in the E1a subunit of PDHc (Matthews et al. 1993); and…”
BackgroundMitochondria and degenerative disorders
Orth, M., & Schapira, A. H. V. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1425 · Cited by 280
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Senoo-Matsuda, N., Yasuda, K., Tsuda, M., Ohkubo, T., Yoshimura, S., Nakazawa, H., Hartman, P. S., & Ishii, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104718200 · Cited by 271
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Bayley, J.-P., Kunst, H. P., Cascon, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H. J., Hoefsloot, L. H., Hermsen, M. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 276
Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
“While homozygote germline mutations affecting the SDHA gene cause Leigh syndrome, a subacute necrotizing encephalomyelopathy during infancy [28–30], SDHD , SDHB and SDHC N I H - PA A u t ho r M anu sc r i p t N I H - PA A u t ho r M anu sc r i p t N I H - PA A u t ho r M anu sc r i p t heterozygous…”
In vivo and in organello assessment of OXPHOS activities
Barrientos, A. (2002) · Methods · doi:10.1016/s1046-2023(02)00036-1 · Cited by 266
van den Heuvel, L., Ruitenbeek, W., Smeets, R., Gelman-Kohan, Z., Elpeleg, O., Loeffen, J., Trijbels, F., Mariman, E., de Bruijn, D., & Smeitink, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301716 · Cited by 263
“Among the inborn errors of metabolism, disturbances in the mitochondrial energy metabolism form a quantitatively major group, occurring in 1/10,000 live births (Bourgeron et al. 1995).”
BackgroundMitochondrial disorders: prevalence, myths and advances
Thorburn, D. R. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031098.41409.55 · Cited by 258
“The frequency of OXPHOS disorders has been said to be 1/5000 to 1/10 000 births (Bourgeron et al 1995; Robinson 1993; Smeitink et al 1998).”
BackgroundSuccinate dehydrogenase and human diseases: new insights into a well-known enzyme
Rustin, P., Munnich, A., & Rötig, A. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200793 · Cited by 257
Self-citationPheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250
Pfleger, J., He, M., & Abdellatif, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.202 · Cited by 250
“which is a progressive neurodegenerative disease associated with neuronal cell death.(10) Likewise, at least one case report shows that a mutation in cII is associated with heart failure,(11)”
BackgroundBenchoua, A., Trioulier, Y., Zala, D., Gaillard, M.-C., Lefort, N., Dufour, N., Saudou, F., Elalouf, J.-M., Hirsch, E., Hantraye, P., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0607 · Cited by 248
“One elegant study showed that, in lymphoblast cells isolated from a patient with homozygous Fp mutations leading to major loss of SDH (Bourgeron et al., 1995), overexpression of a wild-type Fp protein led to a fully functional complex (Parfait et al.”
BackgroundGhezzi, D., Goffrini, P., Uziel, G., Horvath, R., Klopstock, T., Lochmüller, H., D'Adamo, P., Gasparini, P., Strom, T. M., Prokisch, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.378 · Cited by 246
PKM2, a Central Point of Regulation in Cancer Metabolism
Wong, N., De Melo, J., & Tang, D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/242513 · Cited by 243
“Mutations in several enzymes of the TCA-cycle were discovered, including isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2), succinate dehydrogenase (SDH), and fumarate hydratase (FH) [106–109].”
BackgroundAraújo, W. L., Nunes-Nesi, A., Osorio, S., Usadel, B., Fuentes, D., Nagy, R., Balbo, I., Lehmann, M., Studart-Witkowski, C., Tohge, T., et al. (2011) · The Plant Cell · doi:10.1105/tpc.110.081224 · Cited by 240
“In humans, complex II deficiency has been reported both in isolation and in combination with other genetic defects (Morris et al., 1994; Bourgeron et al., 1995; Schon, 2000; Rustin and Rötig, 2002; Rutter et al., 2010), although the precise molecular basesof thesedeficiencies is oftenpoorly…”
BackgroundClinical spectrum and diagnosis of mitochondrial disorders
Munnich, A., & Rustin, P. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1391 · Cited by 239
Self-citationHereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235
Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase
Spinazzola, A., Marti, R., Nishino, I., Andreu, A. L., Naini, A., Tadesse, S., Pela, I., Zammarchi, E., Donati, M. A., Oliver, J. A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111028200 · Cited by 236
Mitochondrial disorders: A proposal for consensus diagnostic criteria in infants and children
Wolf, N. I., & Smeitink, J. A. M. (2002) · Neurology · doi:10.1212/01.wnl.0000031795.91814.d8 · Cited by 230
Mitochondrial Complex II in the Post-ischemic Heart
Chen, Y.-R., Chen, C.-L., Pfeiffer, D. R., & Zweier, J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702294200 · Cited by 230
Gleason, C., Huang, S., Thatcher, L. F., Foley, R. C., Anderson, C. R., Carroll, A. J., Millar, A. H., & Singh, K. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016060108 · Cited by 228
“A notable one is the homozygous mutation in humans, R554Y, which leads to ∼50% decrease in SDH activity, a loss of activation of SDH by ATP, and enhanced oxaloacetate inhibition in isolatedmitochondria as well as results in a Leigh-like syndrome in patients (22).”
BackgroundMitochondrial diseases: from molecular mechanisms to therapeutic advances
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02044-3 · Cited by 222
Lim, S. E., Longley, M. J., & Copeland, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38197 · Cited by 226
The Quaternary Structure of the Saccharomyces cerevisiae Succinate Dehydrogenase
Oyedotun, K. S., & Lemire, B. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311876200 · Cited by 218
Mitochondrial defects in cardiomyopathy and neuromuscular disease
Wallace, D. C. (2000) · American Heart Journal · doi:10.1067/mhj.2000.103934 · Cited by 208
Finsterer, J. (2004) · European Journal of Neurology · doi:10.1046/j.1351-5101.2003.00728.x · Cited by 206
“SDHA 5p15 ar, ad CII Leigh syndrome (Bourgeron et al., 1995)”
BackgroundDiMauro, S. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.014 · Cited by 200
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 197
Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects
Leonard, J., & Schapira, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05226-5 · Cited by 198
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
“Mutations in SDHA were originally described as a cause of autosomal recessive juvenile encephalopathy (Leigh syn- drome; Bourgeron et al. 1995).”
BackgroundSynofzik, M., & Schüle, R. (2017) · Movement Disorders · doi:10.1002/mds.26944 · Cited by 191
Nuclear genetic defects of oxidative phosphorylation
Shoubridge, E. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2277 · Cited by 193
“Missense mutations in the SDHA gene have been found in two families with autosomal recessive LS (16,17) and in a family with a late-onset neurodegenerative disease characterized by optic atrophy, ataxia and myopathy (18).”
BackgroundRespiratory chain complex I deficiency
Triepels, R. H., Van Den Heuvel, L. P., Trijbels, J. M., & Smeitink, J. A. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1397 · Cited by 191
Mechanisms of mitochondrial diseases
Ylikallio, E., & Suomalainen, A. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.598547 · Cited by 185
“Homozygous or compound heterozygous mutations in the SDH-A gene cause LS (26).”
BackgroundShamseldin, H. E., Alshammari, M., Al-Sheddi, T., Salih, M. A., Alkhalidi, H., Kentab, A., Repetto, G. M., Hashem, M., & Alkuraya, F. S. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100836 · Cited by 182
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes
Hirano, M., Nishigaki, Y., & Martí, R. (2004) · The Neurologist · doi:10.1097/01.nrl.0000106919.06469.04 · Cited by 180
“In 1995, the first nDNA mutation causing a mitochondrial respiratory chain defect was identified.(6) In contrast, until 1999, there were no known mutations of nDNA leading to depletion or multiple deletions of mtDNA.”
BackgroundMitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options
Thorburn, D. R., & Dahl, H. M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1380 · Cited by 182
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Leigh Syndrome: Neuropathology and Pathogenesis
Lake, N. J., Bird, M. J., Isohanni, P., & Paetau, A. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000195 · Cited by 172
“However, given the role of succinate dehydrogenase in the citric acid cycle and OXPHOS and given that genetic mutations in succinate dehydrogenase subunits can cause LS (90), 3-nitropropionic acid may be considered to produce a biochemical model of mitochondrial disease.”
BackgroundTaschner, P. E. M., Jansen, J. C., Baysal, B. E., Bosch, A., Rosenberg, E. H., Bröcker‐Vriends, A. H. J. T., van der Mey, A. G. L., van Ommen, G. B., Cornelisse, C. J., & Devilee, P. (2001) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.1144 · Cited by 165
“Previously, only seven mutations have been detected in five of the complex I (NADH: ubiquinone oxidoreductase) genes (Smeitink and van den Heuvel, 1999) and one in the SDHA gene that encodes the flavoprotein subunit of complex II (succinate: ubiquinone oxidoreductase) (Bourgeron et al., 1995).”
BackgroundMitochondrial encephalomyopathies: an update
DiMauro, S., & Hirano, M. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.12.008 · Cited by 163
Mitochondrial complex II and reactive oxygen species in disease and therapy
Hadrava Vanova, K., Kraus, M., Neuzil, J., & Rohlena, J. (2020) · Redox Report · doi:10.1080/13510002.2020.1752002 · Cited by 159
Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies
Lasserre, J.-P., Dautant, A., Aiyar, R. S., Kucharczyk, R., Glatigny, A., Tribouillard‐Tanvier, D., Rytka, J., Blondel, M., Skoczeń, N., Reynier, P., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020438 · Cited by 196
“D is ea se M o d el s & M ec h an is m s siblings affected with LS (Bourgeron et al., 1995).”
Self-citationGenetic heterogeneity in leigh syndrome
Dimauro, S., & de Vivo, D. C. (1996) · Annals of Neurology · doi:10.1002/ana.410400104 · Cited by 160
Mitochondria in neuromuscular disorders
DiMauro, S., Bonilla, E., Davidson, M. M., Hirano, M., & Schon, E. A. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00113-3 · Cited by 160
Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease
Nsiah-Sefaa, A., & McKenzie, M. (2016) · Bioscience Reports · doi:10.1042/bsr20150295 · Cited by 193
Lin, C.-C., Cheng, T., Tsai, W., Tsai, H.-J., Hu, K.-H., Chang, H., Yeh, C., Chen, Y.-C., Liao, C.-C., & Chang, W. (2012) · Scientific Reports · doi:10.1038/srep00785 · Cited by 172
Malina, C., Larsson, C., & Nielsen, J. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy040 · Cited by 175
Clinical presentation of mitochondrial disorders in childhood
Münnich, A., Rötig, A., Chrétien, D., Cormier‐Daire, V., Bourgeron, T., Bonnefont, J., Saudubray, J., & Rustin, P. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799112 · Cited by 154
Self-citationThe molecular and cellular basis of copper dysregulation and its relationship with human pathologies
Maung, M. T., Carlson, A., Olea‐Flores, M., Elkhadragy, L., Schachtschneider, K. M., Navarro‐Tito, N., & Padilla‐Benavides, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100273rr · Cited by 171
Tanaka, M., Szabó, Á., Spekker, E., Polyák, H., Tóth, F., & Vécsei, L. (2022) · Cells · doi:10.3390/cells11162607 · Cited by 166
Teicher, B. A., Linehan, W. M., & Helman, L. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2587 · Cited by 152
“A mutation in a conserved SDH domain in two siblings with complex II deficiency presenting as Leigh syndrome, a rare neurometabolic disorder that affects the central nervous system, caused a mitochondrial respiratory chain deficiency (51).”
Background
Metadata
- Authors
- Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Venue
- Nature Genetics
- Published
- 1995-10
- Volume
- 11
- Issue
- 2
- Pages
- 144-149
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1969931826
- Cited by
- 730
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 12 · 2023: 12 · 2022: 18 · 2021: 21 · 2020: 21 · 2019: 20 · 2018: 18 · 2017: 22 · 2016: 21 · 2015: 22 · 2014: 24 · 2013: 22 · 2012: 39
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- succinate dehydrogenase, Leigh syndrome, mitochondrial respiratory chain deficiency, nuclear gene mutations, homozygous mutation, conserved domains, catalytic activity, gene duplication, yeast complementation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cattle, Cell Nucleus, Chromosome Mapping, Chromosomes, Human, Pair 3, Cloning, Molecular, Consanguinity, Electron Transport Complex IV, Female, Fibroblasts, Homozygote, Humans, Lymphocytes, Male, Mitochondria, Mitochondria, Muscle, Molecular Sequence Data, Multienzyme Complexes, Nuclear Family, Oxidoreductases, Pedigree, Saccharomyces cerevisiae, Succinate Dehydrogenase, Restriction Mapping, Mutagenesis, Site-Directed, Point Mutation, Sequence Homology, Amino Acid, DNA Primers, Muscle, Skeletal, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.